Ding Lingwen
RESEARCH ASSISTANT PROFESSOR, NUS
PRINCIPAL INVESTIGATOR, Nanomedicine Translational Research Programme (NanoMed TRP), NUS
Telephone
ORCID
RESEARCH ASSISTANT PROFESSOR, NUS
PRINCIPAL INVESTIGATOR, Nanomedicine Translational Research Programme (NanoMed TRP), NUS
The research interests of Dr. Ding Lingwen focus on two critical areas in cancer research: developing innovative therapeutic approaches to overcome resistance to cancer immunotherapy; and identifying genetic and epigenetic abnormalities in cancers and pre-cancers. He has authored 68 manuscripts in international journals, over half of them were published in journals with impact factor >10. He also served as an invited ad hoc reviewer and reviewed over 430 manuscripts for 124 international journals. Over the past two years, he has successfully secured more than 2.2 million SGD in research funding as the Principal Investigator (PI), and 3.5 million SGD as Co-Investigator and Collaborator. He also contributes as a Team Principal Investigator to a large CRP (Competitive Research Programme) grant from NRF. He was the recipient of the prestigious Lee Kuan Yew Postdoctoral Fellowship and the Year 2021 Gilead Research Scholars Award (Hematology and Oncology).